India  

AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It is perhaps best known for its involvement in developing the Oxford-Astrazeneca COVID-19 vaccine.

1
shares
ShareTweetSavePostSend
 
EU-AstraZeneca row: both claim victory after Belgian court ruling [Video]

EU-AstraZeneca row: both claim victory after Belgian court ruling

Credit: FRANCE 24 English     Duration: 04:34Published
Boris Johnson pledges one billion vaccinations [Video]

Boris Johnson pledges one billion vaccinations

UK Prime Minister Boris Johnson has pledged one billion doses of the Astra Zeneca vaccine for world wide distribution on behalf of the G7 governments in an effort to accelerate global vaccination...

Credit: ODN     Duration: 01:30Published

Boris Johnson receives second Covid vaccine dose [Video]

Boris Johnson receives second Covid vaccine dose

Prime Minister Boris Johnson has received his second dose of AstraZeneca’s coronavirus vaccine at the Francis Crick Institute in London on Thursday evening.

Credit: PA - Press Association STUDIO     Duration: 01:31Published
EU seeks huge fine in court over AstraZeneca vaccine delivery delays [Video]

EU seeks huge fine in court over AstraZeneca vaccine delivery delays

After months of a bitter dispute over vaccine delivery delays between the European Union and AstraZeneca, a highly publicised trial opened on Wednesday in Brussels.

Credit: euronews (in English)     Duration: 02:20Published
Coronavirus pandemic: EU and Astrazeneca battle in court over vaccine delays [Video]

Coronavirus pandemic: EU and Astrazeneca battle in court over vaccine delays

Credit: FRANCE 24 English     Duration: 03:52Published
Vaccine in numbers: UK passes 60m jabs milestone [Video]

Vaccine in numbers: UK passes 60m jabs milestone

More than 60 million vaccine doses have now been administered in the UK.It comes as a study found the Pfizer and AstraZeneca vaccines are highly effective after two doses against the variant identified..

Credit: PA - Press Association STUDIO     Duration: 00:37Published
Coronavirus: Pfizer and AstraZeneca jabs effective against Indian variant [Video]

Coronavirus: Pfizer and AstraZeneca jabs effective against Indian variant

A study has found the Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses.Health Secretary Matt Hancock said the findings made him..

Credit: PA - Press Association STUDIO     Duration: 01:18Published
Daily politics briefing: May 23 [Video]

Daily politics briefing: May 23

The key facts behind the day's headlines as both the Pfizer and AstraZeneca jabs were found to be highly effective against the B1617.2 strain.

Credit: PA - Press Association STUDIO     Duration: 00:47Published
Kenya's health minister: Africa 'must stop believing' world will help [Video]

Kenya's health minister: Africa 'must stop believing' world will help

CNN’s Larry Madowo speaks with Kenyan health minister Mutahi Kagwe as the East African nation is now just days away from running out of Covid-19 vaccines, with only about 100,000 AstraZeneca doses..

Credit: Bleacher Report AOL     Duration: 02:30Published
Biden announces US will share more vaccines globally [Video]

Biden announces US will share more vaccines globally

President Joe Biden announced that his administration will share millions more doses of Covid-19 vaccines with other countries in addition to the 60 million doses of the AstraZeneca vaccine he has..

Credit: Bleacher Report AOL     Duration: 02:12Published
Mixing Covid-19 vaccines 'could increase side effects' [Video]

Mixing Covid-19 vaccines 'could increase side effects'

Researchers from the Oxford Vaccine Group's Com-COV vaccine trial discovered that adults were more likely to suffer from mild to moderate side effects after mixing doses of the AstraZeneca and Pfizer..

Credit: Cover Video STUDIO     Duration: 01:22Published
Vaccine in numbers: More than 18 million second jabs given [Video]

Vaccine in numbers: More than 18 million second jabs given

More than 18 million second coronavirus jabs have been given in the UK, along with 35,587,348 first doses. The statistics come after protesters demanded that AstraZeneca share its Covid-19 vaccine..

Credit: PA - Press Association STUDIO     Duration: 00:37Published
European Union opts not to renew AstraZeneca vaccines contract after supply row [Video]

European Union opts not to renew AstraZeneca vaccines contract after supply row

Commissioner Thierry Breton says a post-June order has not been made as French President Emmanuel Macron says the bloc will focus on different vaccines

Credit: euronews (in English)     Duration: 01:00Published
Taoiseach receives AstraZeneca vaccine [Video]

Taoiseach receives AstraZeneca vaccine

The Taoiseach expressed hope that Ireland can look forward to a good summer as he received his first Covid-19 vaccination.Micheal Martin was given an AstraZeneca jab at the Cork City Hall vaccination..

Credit: PA - Press Association STUDIO     Duration: 00:30Published
Age threshold for alternative to AstraZeneca jab raised [Video]

Age threshold for alternative to AstraZeneca jab raised

Under-40s are to be offered an alternative to the Oxford/AstraZeneca Covid-19 vaccine as a precautionary move.

Credit: PA - Press Association STUDIO     Duration: 00:38Published
Under-40s in UK to get alternative Covid jab to AstraZeneca [Video]

Under-40s in UK to get alternative Covid jab to AstraZeneca

Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab. The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk"..

Credit: ODN     Duration: 01:00Published
Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other..

Credit: ANI     Duration: 01:57Published
UK agreed to expand partnership on vaccines: MEA [Video]

UK agreed to expand partnership on vaccines: MEA

Prime Minister Narendra Modi held a virtual summit with his UK counterpart Boris Johnson on May 04. Speaking on the talks between the two leaders, MEA Joint Secretary (Europe West), Sandeep Chakraborty..

Credit: ANI     Duration: 01:13Published
Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge [Video]

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge

Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over..

Credit: HT Digital Content     Duration: 02:05Published
‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls [Video]

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls

Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a..

Credit: HT Digital Content     Duration: 01:50Published
‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India [Video]

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India

Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country..

Credit: HT Digital Content     Duration: 01:43Published
Europe's week: Vaccine passports, Brexit, Sofagate and AstraZeneca [Video]

Europe's week: Vaccine passports, Brexit, Sofagate and AstraZeneca

These are the key stories from the Brussels bubble this week.

Credit: Euronews English     Duration: 07:00Published

You Might Like


Vietnam to receive 1 million doses of AstraZeneca vaccine weekly from July


IndiaTimes - Published

AstraZeneca top expert backs India on widening Covishield dose gap


IndiaTimes - Published

When should you take second dose of Covishield vaccine? AstraZeneca says THIS

AstraZeneca on Friday backed the idea of keeping a 12-16 weeks gap between the two doses of the Covishield vaccine.
DNA - Published

AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap


IndiaTimes - Published

AstraZeneca and EU both claim win as court rules on vaccine supply row

astrazeneca and eu both claim win as court rules on vaccine supply row
AstraZeneca and the EU have both claimed victory in a court ruling over the supply of COVID-19 vaccines.
Sky News - Published

Covishield produces more antibodies than Covaxin, finds study

Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..
IndiaTimes - Published

US to ease Covid vaccine input supply: Kamala Harris to PM Modi

US Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..
IndiaTimes - Published

Boris Johnson receives second dose of AstraZeneca COVID vaccine

Boris Johnson has had his second dose of the AstraZeneca COVID vaccine.
Sky News - Published

UK government negotiating with AstraZeneca to secure South African variant vaccine

uk government negotiating with astrazeneca to secure south african variant vaccine
The UK government has begun negotiations with AstraZeneca to secure a "variant vaccine" that can tackle the South African variant, Health Secretary Matt Hancock has said.
Sky News - Published

US redirects vaccine manufacturing supplies allowing India to make additional 20 million Covid vaccine doses

The US government on Friday redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca Covid-19 vaccines.
IndiaTimes - Published

ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin


IndiaTimes - Published

Small number of people suffer stroke after AstraZeneca jab - as experts urge doctors to be alert

small number of people suffer stroke after astrazeneca jab - as experts urge doctors to be alert
Doctors have been told to look out for signs of stroke in patients who received the Oxford/AstraZeneca coronavirus jab after one person died and two others needed hospital treatment.
Sky News - Published

Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study

Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India, a new UK..
IndiaTimes - Published

'It would be a disaster': Vaccine hesitancy in some African nations risks jabs going out of date

'it would be a disaster': vaccine hesitancy in some african nations risks jabs going out of date
When the world-wide vaccine alliance, GAVI, announced that 132,000 AstraZeneca vaccines had been designated for South Sudan, doctors and health officials in this impoverished country were both..
Sky News - Published

3-month gap between doses improves immune response: AZ vax co-developer

A three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and..
IndiaTimes - Published

'Morally wrong' to offer COVID jabs to children while poorer nations suffer, says Oxford expert

'morally wrong' to offer covid jabs to children while poorer nations suffer, says oxford expert
It is "morally wrong" to offer coronavirus jabs to children in wealthy countries when people at greater risk in poorer nations remain unvaccinated, one of the scientists behind the Oxford-AstraZeneca..
Sky News - Published

Biggest AstraZeneca jab maker unlikely to resume exports 'for at least three months'

biggest astrazeneca jab maker unlikely to resume exports 'for at least three months'
The world's biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India's coronavirus crisis.
Sky News - Published

26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt


IndiaTimes - Published

Under-40s to be offered alternative to Oxford jab over blood clot fears

All under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine as a precaution.
Sky News - Published

US 'doing a lot for India' to meet Covid crisis: Joe Biden

President Joe Biden has said that the US was "doing a lot for India" by sending it oxygen and materials to make anti-Covid-19 vaccines. Biden's spokesperson Jen Psaki said that the US government was..
IndiaTimes - Published

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India via the UN-backed COVAX, an initiative devised to give countries access to coronavirus vaccines regardless of their wealth.
IndiaTimes - Published

Serum Institute plans to start Covid vaccine production outside India: Report

The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..
IndiaTimes - Published

5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh Varma

New Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1. Sputnik V is the third vaccine India has..
DNA - Published

India's COVID crisis: US to redirect 20M doses of AstraZeneca vaccines, send raw material to make 5,00,000 doses

Over the weekend, the US announced that it will be diverting raw material to India for manufacturing of COVID-19 vaccines in the country.
DNA - Published

US to share up to 60 million doses of AstraZeneca vaccine with the world

us to share up to 60 million doses of astrazeneca vaccine with the world
The US will share up to 60 million doses of the AstraZeneca vaccine with the world, the White House has said.
Sky News - Published

EU Commission sues AstraZeneca over vaccine contract

eu commission sues astrazeneca over vaccine contract
The European Commission has launched legal action against AstraZeneca for not respecting a contract for the supply of COVID-19 vaccines.
Sky News - Published

EU takes legal action against AstraZeneca over vaccine supply

A legal case has been started by the European Commission against AstraZeneca over its "complete failure" to meet delivery and contractual agreements, Ireland's health minister has said.
Sky News - Published

How big is risk of clots from Covishield?

The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if patients report them early.
IndiaTimes - Published

UNICEF says AstraZeneca supply issues outside India resolved


IndiaTimes - Published

Family of Italian woman who died after Oxford jab launch legal action

family of italian woman who died after oxford jab launch legal action
The family of an Italian woman who died weeks after having the Oxford-AstraZeneca coronavirus vaccine have told Sky News they are taking legal action to establish whether the jab was to blame.
Sky News - Published

Risk of blood clot after COVID is eight times higher than after AstraZeneca jab - study

risk of blood clot after covid is eight times higher than after astrazeneca jab - study
The risk of developing a blood clot after having COVID-19 is eight times higher than after being given the Oxford-AstraZeneca vaccine, according to a study by Oxford University.
Sky News - Published

European Medicines Agency issues post-vax adverse-event alert for medics

The safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical professionals to look out for cases of unusual..
IndiaTimes - Published

'It's been a massive achievement': Former AstraZeneca board member defends firm over vaccine

'it's been a massive achievement': former astrazeneca board member defends firm over vaccine
A former AstraZeneca board member has told Sky News that she thinks the company has been unfairly criticised over its handling of the vaccine rollout.
Sky News - Published

India to review Covid-19 vaccines after blood clot warning: Report

A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two Covid-19 vaccines being administered in India, a media report said..
IndiaTimes - Published

Blood clot victim's sister 'very angry' but says everyone should have Oxford jab

blood clot victim's sister 'very angry' but says everyone should have oxford jab
The sister of a man who died from a blood clot after receiving the Oxford-AstraZeneca vaccine has said she is "very angry" but still "strongly" believes people should have the vaccine.
Sky News - Published

More than 700,000 doses of AstraZeneca jab 'flown from UK to Australia'

more than 700,000 doses of astrazeneca jab 'flown from uk to australia'
More than 700,000 doses of the Oxford-AstraZeneca vaccine have been flown from the UK to Australia, it has been reported.
Sky News - Published

Oxford jab scientist set for £20m windfall in 'New York flotation'

oxford jab scientist set for £20m windfall in 'new york flotation'
The scientist who led the development of the Oxford University-AstraZeneca coronavirus vaccine is on course for a payday of more than £20m through a stock market listing, according to reports.
Sky News - Published

'Full speed ahead' for vaccine rollout - but 18 to 29-year-olds to be offered alternative to Oxford jab

'full speed ahead' for vaccine rollout - but 18 to 29-year-olds to be offered alternative to oxford jab
Boris Johnson has said the roadmap out of lockdown will not be affected by the decision to offer 18 to 29-year-olds an alternative to the Oxford-AstraZeneca vaccine.
Sky News - Published

AstraZeneca sends legal notice to SII over delays in vaccine supply


IndiaTimes - Published

What is the AstraZeneca blood clot risk and how does it compare?

what is the astrazeneca blood clot risk and how does it compare?
The use of the Oxford-AstraZeneca vaccine in those under 30 is to be limited due to concerns over blood clots - but what exactly is the risk and how does it compare?
Sky News - Published

Serum Institute asks government for $403 million to boost AstraZeneca vaccine output

The Serum Institute of India has asked the government for a grant of 30 billion rupees ($402.97 million) to increase its capacity to make AstraZeneca's Covid-19 vaccine. It is seeking the money to ramp..
IndiaTimes - Published

'Unusual blood clots' should be listed as 'very rare' side effect of Oxford vaccine, EU regulator says

The European medicines regulator says that "unusual blood clots" should be listed as "very rare" side-effects of the Oxford-AstraZeneca COVID vaccine.
Sky News - Published

Britons aged 18-29 to be offered alternative to Oxford jab

Britons aged 18-29 will be offered an alternative to the Oxford-AstraZeneca vaccine where available, government advisors have decided.
Sky News - Published

Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people?

does the astrazeneca vaccine still pass the risk-benefit analysis for young people?
The greater the risk of a disease, the greater the risk doctors would be prepared to take to prevent it.
Sky News - Published

Everything you need to know about the Moderna vaccine

everything you need to know about the moderna vaccine
The Moderna coronavirus vaccine is the third jab to be rolled out in the UK, alongside the Pfizer/BioNTech and Oxford University-AstraZeneca jabs.
Sky News - Published

UK trial of Oxford COVID jab on children paused as regulator probes blood clots in adults

A trial of the Oxford-AstraZeneca COVID vaccine on children in the UK has been paused while the medicines regulator investigates a possible link between the jab and rare blood clots in adults.
Sky News - Published

EU medical regulator's chief: 'Increasingly difficult' to say no link between Oxford jab and rare blood clots

The head of the European Medicines Agency (EMA) has said it is "increasingly difficult" to say there is "no cause and effect relationship" between the Oxford-AstraZeneca jab and "rare cases of unusual..
Sky News - Published

 Page 1  〉